Close Menu

NEW YORK (GenomeWeb) – Pathology Associates Medical Laboratories (PAML) today announced that it has entered into a collaboration with Axela to develop multiplex assays to detect patient immunity to diseases that can be prevented with vaccines.

The serologic assays will measure antibodies to a wide range of viruses including measles, mumps, and rubella to help determine a patient's immunity to those diseases. The terms of the agreement also call for multiplex targets beyond the initial serological assays.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.